Liza Hoveling

PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands, Netherlands

Poster(s):

• (003) Survival and drug treatment patterns in multiple myeloma patients exposed to an anti-CD38 monoclonal antibody, a proteasome inhibitor and an immunomodulatory imide drugs
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT